Pharmaceuticals, Biotechnology and Life Sciences
Verona Pharma posted Monday expanded analysis to positive results from March, from from findings from its chronic obstructive pulmonary disease (“COPD”) clinical trial program with lead product candidate, ensifentrine (RPL554). Positive results from the 4-week, 400-patient Phase 2b study were initially reported in March 2018.
LEHI, Utah–(BUSINESS WIRE)–Frelii Inc. (OTCQB: FRLI) (“Frelii” or “the Company”) today announced that on May 20, 2019, it filed with…
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/guthealth?src=hash" target="_blank"gt;#guthealthlt;/agt;–Gemelli Biotech, in partnership with the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, announced…
WASHINGTON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/BIOWC19?src=hash" target="_blank"gt;#BIOWC19lt;/agt;–The Biotechnology Innovation Organization (BIO) today announced that former U.S. Department of Agriculture (USDA) Secretary and former…
U.S. District Court rules Dana-Farber scientist Gordon Freeman, PhD,was co-inventor of all six patents in issue
– Ongoing Phase 2 ACCURACY study to explore AL101 and its effect on tumor growth inhibition in people with Adenoid…
The global pulmonary embolism therapeutics market is expected to post aCAGR of more than 9% during the period 2019-2023, according to thelatest market research report by Technavio.
New Drug Application for HP-3070 under FDA review MIAMI & JERSEY CITY, N.J.–(BUSINESS WIRE)–Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of…
DUBLIN–(BUSINESS WIRE)–The “Global Clinical In Vitro Diagnostic Medical Laboratory Services Market 2019 to 2023 – Strategies & Trends, Volume &…
DUBLIN–(BUSINESS WIRE)–The “Atopic Dermatitis: Global Drug Forecast and Market Analysis to 2027” report has been added to ResearchAndMarkets.com’s offering. The…